参考文献/References:
[1].中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
[2].赵冬. 心血管疾病危险因素的研究:过去、现在和未来[J]. 中国循环杂志,2021,36(1):1-3.
[3].Moosa AA,Abed MS. Graphene preparation and graphite exfoliation[J]. Turk J Chem,2021,45(3):493-519.
[4].Suvarnaphaet P,Pechprasarn S. Graphene-based materials for biosensors:a review[J]. Sensors(Basel),2017,17(10):2161.
[5].Venkataraman A,Amadi EV,Chen Y,et al. Carbon n anotube assembly and integration for applications[J]. Nanoscale Res L ett,2019,14(1):220.
[6].[6] Kaya D,Kü?ükada K,Alemdar N. Modeling the drug release from reduced graphene oxide-reinforced hyaluronic acid/gelatin/poly(ethylene oxide) polymeric films[J]. Carbohydr Polym,2019,215:189-197.
[7].[7] Paul A,Hasan A,Kindi HA,et al. Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair[J]. ACS Nano,2014,8(8):8050-8062.
[8].[8] Masotti A,Miller MR,Celluzzi A,et al. Regulation of angiogenesis through the efficient delivery of microRNAs into endothelial cells using polyamine-coated carbon nanotubes[J]. Nanomedicine,2016,12(6):1511-1522.
[9]. [9] Ul Haq A,Carotenuto F,di Nardo P,et al. Extrinsically conductive nanomaterials for cardiac tissue engineering applications[J]. Micromachines (Basel),2021,12(8):914.
[10].[10]Hao T,Zhou J,Lü S,et al. Fullerene mediates proliferation and cardiomyogenic differentiation of adipose-derived stem cells via modulation of MAPK pathway and cardiac protein expression[J]. Int J Nanomedicine,2016,11:269-283.
[11].[11]Demirbakan B,Kemal Sezgintürk M. A novel ultrasensitive immunosensor based on disposable graphite paper electrodes for troponin T detection in cardiovascular disease[J]. Talanta,2020,213:120779.
[12].[12]Chauhan D,Pooja,Nirbhaya V,et al. Nanostructured transition metal chalcogenide embedded on reduced graphene oxide based highly efficient biosensor for cardiovascular disease detection[J]. Microchem J,2020,155:104697.
[13].[13]Freitas TA,Mattos AB,Silva BVM,et al. Amino-functionalization of carbon nanotubes by using a factorial design:human cardiac troponin T immunosensing application[J]. BioMed Res Int,2014,2014:929786.
[14].[14]Eissa S,Almusharraf AY,Zourob M. A comparison of the performance of voltammetric aptasensors for glycated haemoglobin on different carbon nanomaterials-modified screen printed electrodes[J]. Mater Sci Eng C Mater Biol Appl,2019,101:423-430.
[15].[15] Gerstenhaber JA,Barone FC,Marcinkiewicz C,et al. Vascular thrombus imaging in vivo via near-infrared fluorescent nanodiamond particles bioengineered with the disintegrin bitistatin (Part Ⅱ)[J]. Int J Nanomedicine,2017,12:8471-8482.
[16].[16]Wang C,Li J,Kang M,et al. Nanodiamonds and hydrogen-substituted graphdiyne heteronanostructure for the sensitive impedimetric aptasensing of myocardial infarction and cardiac troponin I[J]. Anal Chim Acta,2021,1141:110-119.
[17].[17]Nazari H,Azadi S,Hatamie S,et al. Fabrication of graphene-silver/polyurethane nanofibrous scaffolds for cardiac tissue engineering[J]. Polym Adv Technol,2019,30(8):2086-2099.
[18].[18]Bao R,Tan S,Liang S,et al. A π-π conjugation-containing soft and conductive injectable polymer hydrogel highly efficiently rebuilds cardiac function after myocardial infarction[J]. Biomaterials,2017,122:63-71.
[19]. [19]Ahadian S,Davenport HL,Estili M,et al. Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac tissue engineering[J]. Acta Biomater,2017,52:81-91.
[20].[20]Kharaziha M,Shin SR,Nikkhah M,et al. T ough and flexible CNT-polymeric hybrid scaffolds for engineering cardiac constructs[J]. Biomaterials,2014,35(26):7346-7354.
[21].[21]Hao T,Li J,Yao F,et al. Injectable fullerenol/alginate hydrogel for suppression of oxidative stress damage in Brown adipose-derived stem cells and cardiac repair[J]. ACS Nano,2017,11(6):5474-5488.
[22].[22]Malanagahalli S,Murera D,Martín C,et al. Few layer graphene does not affect cellular homeostasis of mouse macrophages[J]. Nanomaterials(Basel),2020,10(2):228.
[23].[23]Han J,Kim YS,Lim MY,et al. Dual roles of graphene oxide to attenuate inflammation and elicit timely polarization of macrophage phenotypes for cardiac repair[J]. ACS Nano,2018,12(2):1959-1977.
[24].[24]Yuan X,Zhang X,Sun L,et al. Cellular toxicity and immunological effects of carbon-based nanomaterials[J]. Part Fibre Toxicol,2019,16(1):18.
[25].[25]Bunz H,Plankenhorn S,Klein R. Effect of buckminsterfullerenes on cells of the innate and adaptive immune system:an in vitro study with human peripheral blood mononuclear cells[J]. Int J Nanomedicine,2012,7:4571-4580.
[26].[26]Suarez-Kelly LP,Campbell AR,Rampersaud IV,et al. Fluorescent nanodiamonds engage innate immune effector cells:a potential vehicle for targeted anti-tumor immunotherapy[J]. N anomedicine,2017,13(3):909-920.
[27].[27]Madannejad R,Shoaie N,Jahanpeyma F,et al. Toxicity of carbon-based nanomaterials:reviewing recent reports in medical and biological systems[J]. Chem Biol Interact,2019,307:206-222.
[28].[28]Chen Z,Yu C,Khan IA,et al. Toxic effects of different-sized graphene oxide particles on zebrafish embryonic development[J]. Ecotoxicol Environ Saf,2020,197:110608.
[29].[29]刘永智,解立强,梁盛德,等. C60对细胞膜潜在生物毒性的分子动力学模拟[J].计算物理,2020,37(4):479-487.
[30].[30] Hansen SF,Lennquist A. Carbon nanotubes added to the SIN List as a nanomaterial of Very High Concern[J]. Nat Nanotechnol,2020,15(1):3-4.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(4):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(4):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(4):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(4):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(4):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(4):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]